No abstract available
Keywords:
formulation approaches; nanocarriers; non-small-cell lung cancer (NSCLC); pulmonary delivery; sorafenib; tyrosine-kinase inhibitor.
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Cell Line, Tumor
-
Humans
-
Lung Neoplasms / drug therapy*
-
Nanotechnology / trends*
-
Sorafenib / therapeutic use*
Substances
-
Antineoplastic Agents
-
Sorafenib